Antibody Research

School of Medicine researchers have designed a synthetic protein against COVID-19. Dr. Jay Kolls, John W. Deming Endowed Chair in Internal Medicine and lead author of the research, said the engineered protein, called MDR504, is designed to go to the lungs to neutralize the virus before it can infect lung cells. In addition to a treatment, the protein could be used as a pre- or post-exposure therapy for healthcare workers, first responders and vulnerable populations at high risk.

Horizontal thumbnail